Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Effect of redox imbalance on protein modifications in lymphocytes of psoriatic patients.

Wójcik P, Gęgotek A, Wroński A, Jastrząb A, Żebrowska A, Skrzydlewska E.

J Biochem. 2019 Nov 9. pii: mvz096. doi: 10.1093/jb/mvz096. [Epub ahead of print]

PMID:
31710683
2.

Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.

Elman JS, Ni TK, Mengwasser KE, Jin D, Wronski A, Elledge SJ, Kuperwasser C.

Cell Rep. 2019 Sep 24;28(13):3435-3449.e5. doi: 10.1016/j.celrep.2019.08.060.

3.

Altered Lipid Metabolism in Blood Mononuclear Cells of Psoriatic Patients Indicates Differential Changes in Psoriasis Vulgaris and Psoriatic Arthritis.

Wójcik P, Biernacki M, Wroński A, Łuczaj W, Waeg G, Žarković N, Skrzydlewska E.

Int J Mol Sci. 2019 Aug 30;20(17). pii: E4249. doi: 10.3390/ijms20174249.

4.

Synthego's Engineered Cells Allow Scientists to "Cut Out" CRISPR Optimization [SPONSORED].

Enzmann BL, Wronski A.

CRISPR J. 2018 Aug;1:255-257. doi: 10.1089/crispr.2018.29022.pro. No abstract available.

PMID:
31021223
5.

The Proteomic Profile of Keratinocytes and Lymphocytes in Psoriatic Patients.

Gęgotek A, Domingues P, Wroński A, Ambrożewicz E, Skrzydlewska E.

Proteomics Clin Appl. 2019 Jul;13(4):e1800119. doi: 10.1002/prca.201800119. Epub 2019 Jan 25.

PMID:
30648813
6.

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer.

Milevskiy MJG, Sandhu GK, Wronski A, Korbie D, Brewster BL, Shewan A, Edwards SL, French JD, Brown MA.

Oncotarget. 2018 Sep 11;9(71):33577-33588. doi: 10.18632/oncotarget.26094. eCollection 2018 Sep 11.

7.

Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients.

Ambrożewicz E, Wójcik P, Wroński A, Łuczaj W, Jastrząb A, Žarković N, Skrzydlewska E.

Cells. 2018 Oct 6;7(10). pii: E159. doi: 10.3390/cells7100159.

8.

Proteomic plasma profile of psoriatic patients.

Gęgotek A, Domingues P, Wroński A, Wójcik P, Skrzydlewska E.

J Pharm Biomed Anal. 2018 Jun 5;155:185-193. doi: 10.1016/j.jpba.2018.03.068. Epub 2018 Apr 4.

PMID:
29635173
9.

Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers.

Olsen SN, Wronski A, Castaño Z, Dake B, Malone C, De Raedt T, Enos M, DeRose YS, Zhou W, Guerra S, Loda M, Welm A, Partridge AH, McAllister SS, Kuperwasser C, Cichowski K.

Cancer Discov. 2017 Feb;7(2):202-217. doi: 10.1158/2159-8290.CD-16-0520. Epub 2016 Dec 14.

10.

The SIRT2 Deacetylase Stabilizes Slug to Control Malignancy of Basal-like Breast Cancer.

Zhou W, Ni TK, Wronski A, Glass B, Skibinski A, Beck A, Kuperwasser C.

Cell Rep. 2016 Oct 25;17(5):1302-1317. doi: 10.1016/j.celrep.2016.10.006.

11.

Cell Fate Decisions During Breast Cancer Development.

Gross K, Wronski A, Skibinski A, Phillips S, Kuperwasser C.

J Dev Biol. 2016 Mar 1;4(1):4. Epub 2016 Jan 22.

12.

MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland.

Wronski A, Sandhu GK, Milevskiy MJ, Brewster BL, Bridge JA, Shewan AM, Edwards SL, French JD, Brown MA.

Oncogenesis. 2016 Apr 4;5:e218. doi: 10.1038/oncsis.2016.27.

13.

The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation.

Gęgotek A, Biernacki M, Ambrożewicz E, Surażyński A, Wroński A, Skrzydlewska E.

J Dermatol Sci. 2016 Feb;81(2):107-17. doi: 10.1016/j.jdermsci.2015.11.005. Epub 2015 Dec 1.

PMID:
26674123
14.

Humanization of the mouse mammary gland.

Wronski A, Arendt LM, Kuperwasser C.

Methods Mol Biol. 2015;1293:173-86. doi: 10.1007/978-1-4939-2519-3_10.

PMID:
26040688
15.

Human breast progenitor cell numbers are regulated by WNT and TBX3.

Arendt LM, St Laurent J, Wronski A, Caballero S, Lyle SR, Naber SP, Kuperwasser C.

PLoS One. 2014 Oct 28;9(10):e111442. doi: 10.1371/journal.pone.0111442. eCollection 2014.

16.

Cell-state transitions regulated by SLUG are critical for tissue regeneration and tumor initiation.

Phillips S, Prat A, Sedic M, Proia T, Wronski A, Mazumdar S, Skibinski A, Shirley SH, Perou CM, Gill G, Gupta PB, Kuperwasser C.

Stem Cell Reports. 2014 Apr 24;2(5):633-47. doi: 10.1016/j.stemcr.2014.03.008. eCollection 2014 May 6.

17.

NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.

Kottakis F, Foltopoulou P, Sanidas I, Keller P, Wronski A, Dake BT, Ezell SA, Shen Z, Naber SP, Hinds PW, McNiel E, Kuperwasser C, Tsichlis PN.

Cancer Res. 2014 Jul 15;74(14):3935-46. doi: 10.1158/0008-5472.CAN-13-2733. Epub 2014 May 22.

18.

De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans.

Morrow CA, Valkov E, Stamp A, Chow EW, Lee IR, Wronski A, Williams SJ, Hill JM, Djordjevic JT, Kappler U, Kobe B, Fraser JA.

PLoS Pathog. 2012;8(10):e1002957. doi: 10.1371/journal.ppat.1002957. Epub 2012 Oct 11.

19.

Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.

Smart CE, Askarian Amiri ME, Wronski A, Dinger ME, Crawford J, Ovchinnikov DA, Vargas AC, Reid L, Simpson PT, Song S, Wiesner C, French JD, Dave RK, da Silva L, Purdon A, Andrew M, Mattick JS, Lakhani SR, Brown MA, Kellie S.

PLoS One. 2012;7(7):e40742. doi: 10.1371/journal.pone.0040742. Epub 2012 Jul 17.

20.

Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.

Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen X, Bove B; kConFab, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P.

Hum Mutat. 2012 Dec;33(12):1665-75. doi: 10.1002/humu.22159. Epub 2012 Aug 2.

PMID:
22753153
21.

Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit.

Smart CE, Wronski A, French JD, Edwards SL, Asselin-Labat ML, Waddell N, Peters K, Brewster BL, Brooks K, Simpson K, Manning N, Lakhani SR, Grimmond S, Lindeman GJ, Visvader JE, Brown MA.

Oncogene. 2011 Mar 31;30(13):1597-607. doi: 10.1038/onc.2010.538. Epub 2010 Dec 6.

PMID:
21132007
22.

Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants.

Pettigrew CA, Wayte N, Wronski A, Lovelock PK, Spurdle AB, Brown MA.

Breast Cancer Res Treat. 2008 Jul;110(2):227-34. Epub 2007 Sep 26.

PMID:
17899372
23.

Aspects of abstinence after morphine ingestion.

Rönnbäck L, Eriksson PS, Zeuchner J, Rosengren L, Wronski A.

Pharmacol Biochem Behav. 1987 Sep;28(1):87-93.

PMID:
3659110
24.

Efficacy of a new quinolone in acute male gonorrhea.

Szarmach H, Weuta H, Podziewski J, Skarzynski J, Wronski A.

Chemioterapia. 1987 Jun;6(2 Suppl):548. No abstract available.

PMID:
3509496
25.

Ciprofloxacin in acute male gonorrhea.

Szarmach H, Weuta H, Podziewski J, Skarzynski J, Wronski A.

Arzneimittelforschung. 1986 Dec;36(12):1840-2.

PMID:
3566847
26.

[Mixed infections of the urogenital tract with Trichomonas vaginalis and yeast-like fungi in humans with reference to treatment].

Szarmach H, Małyszko E, Wroński A, Niczyporuk W, Roszkiewicz J.

Z Hautkr. 1986 Feb 1;61(3):146-9. German.

PMID:
3754079
27.

[Drug-induced skin reactions in the light of clinical and morphological studies].

Szarmach H, Reduta T, Wroński A, Niczyporuk W, Roszkiewicz J.

Przegl Dermatol. 1985 Nov-Dec;72(6):521-6. Polish. No abstract available.

PMID:
2938218
28.

Long lasting changes in gerbil brain after chronic ethanol exposure: a quantitative study of the glial cell marker S-100 and DNA.

Rosengren LE, Wronski A, Briving C, Haglid KG.

Alcohol Clin Exp Res. 1985 Mar-Apr;9(2):109-13.

PMID:
3890588
29.

[Trichomoniasis of the urogenital tract in patients hospitalized in 1976-1983].

Szarmach H, Małyszko E, Wroński A, Niczyporuk W, Roszkiewicz J.

Z Hautkr. 1985 Feb 1;60(3):261-4, 269. German.

PMID:
3873142
30.

Decreased morphine intake by opiate addicted rats administered zimelidine, a 5-HT uptake inhibitor.

Rönnbäck L, Zeuchner J, Rosengren L, Wronski A, Ogren SO.

Psychopharmacology (Berl). 1984;82(1-2):30-5.

PMID:
6229805
31.

[Effect of different cytostatic agents and antibiotics on the biology of Trichomonas in vitro].

Szarmach H, Małyszko E, Wroński A.

Z Hautkr. 1983 Aug 15;58(16):1183-90. German.

PMID:
6624178
32.

[Diagnostic and epidemiologic significance of multinuclear and round forms of Trichomonas vaginalis].

Szarmach H, Małyszko E, Wroński A, Niczyporuk E.

Z Hautkr. 1983 Aug 15;58(16):1179-82. German.

PMID:
6605001
33.

[Sisomicin in the treatment of gonorrhea].

Szarmach H, Weuta H, Wroński A, Niezyporuk W, Podziewski J, Skarzyński J.

Med Welt. 1983 Jun 24;34(25-26):734-5. German. No abstract available.

PMID:
6412032
34.

[Diagnostic and epidemiological problems in coexisting candidiasis and trichomoniasis in the human urogenital tract].

Szarmach H, Małyszko E, Wroński A.

Mykosen. 1983 Jun;26(6):285-90. German. No abstract available.

PMID:
6888419
35.

[Leukocyte migration inhibition test in syphilis].

Wroński A, Szarmach H.

Przegl Dermatol. 1983 May-Jun;70(3):269-72. Polish. No abstract available.

PMID:
6665186
36.

Clinical studies on the effectiveness of Wratizolin in the treatment of some dermatoses.

Szarmach H, Wroński A, Laudańska H, Niczyporuk W.

Arch Immunol Ther Exp (Warsz). 1983;31(5):655-61.

PMID:
6675573
37.
38.

A new ingestion method for long-term morphine intoxication in rat.

Zeuchner J, Rosengren L, Wronski A, Rönnbäck L.

Pharmacol Biochem Behav. 1982 Sep;17(3):495-501.

PMID:
6890685
39.

[Problems of contact allergy to topical drugs].

Szarmach H, Wroński A, Podziewski J.

Przegl Dermatol. 1982 Jul-Aug;69(4):239-44. Polish. No abstract available.

PMID:
7184052
40.

[An attempt to estimate the pathogenicity of yeast-like fungi based on enzymatic properties of the fungus and on a skin infection model in the white mouse (author's transl)].

Szarmach H, Małyszko E, Wroński A, Niczyporuk W.

Mykosen. 1982 Apr;25(4):210-20. German. No abstract available.

PMID:
7045656
41.

The influence of early protein-calorie malnutrition and postnatal rehabilitation on levels of a brain-specific protein (S 100) in discrete rat brain areas.

Wroński A, Haglid KG, Rosengren L, Rönnbäck L, Sourander P.

Acta Neuropathol. 1982;56(2):81-6. No abstract available.

PMID:
6801914
42.

[Yeast-like flora of the male and female urogenital system with regard to enzymatic activity and clinical symptoms].

Szarmach H, Małyszko E, Wroński A, Niczyporuk W.

Przegl Dermatol. 1982 Jan-Apr;69(1-2):47-51. Polish. No abstract available.

PMID:
6758044
43.

Trichloroethylene: long-lasting changes in the brain after rehabilitation.

Haglid KG, Briving C, Hansson HA, Rosengren L, Kjellstrand P, Stavron D, Swedin U, Wronski A.

Neurotoxicology. 1981 Dec;2(4):659-73.

PMID:
7200581
44.

[Virulence of candida-like fungi, isolated from the urogenital tract (author's transl)].

Szarmach H, Małyszko E, Wroński A, Niczyporuk W.

Z Hautkr. 1981 Oct 1;56(19):1265-74. German.

PMID:
7032102
45.

[Lymphocyte transformation test in syphilis].

Wroński A, Szarmach H, Moniuszko T.

Przegl Dermatol. 1981 Jul-Aug;68(4):471-4. Polish. No abstract available.

PMID:
7330231
46.

[Skin changes in children with malabsorption syndrome].

Kaczmarski M, Taraszkiewicz F, Kurasz S, Borowska Z, Szałkowska E, Fiedorowicz J, Wroński A.

Przegl Dermatol. 1981 May-Jun;68(3):317-23. Polish. No abstract available.

PMID:
6458071
47.

[Skin changes and malabsorption syndromes].

Kaczmarski M, Taraszkiewicz F, Fiedorowicz J, Wroński A.

Pediatr Pol. 1981;56(4):455-60. Polish. No abstract available.

PMID:
7267219
48.

[Clinical, histological, ultrastructural and biochemical studies on the effectiveness of hydroxyurea in the treatment of psoriasis].

Szarmach H, Niczyporuk W, Poniecka H, Kurasz S, Zdrodowska-Stefanow B, Skarzyński J, Wroński A.

Przegl Dermatol. 1981 Jan-Feb;68(1):71-8. Polish. No abstract available.

PMID:
7244263
49.

[Clinical, bacteriological and histological examinations in the utilization of Baycuten cream].

Szarmach H, Weuta H, Wrónski A, Poniecka H, Niczyporuk W, Zaremba A, Trybuła I.

Med Welt. 1980 Nov 28;31(48):1763-6. German. No abstract available.

PMID:
7464528
50.

[Role of psychosocial factors in venereal diseases].

Midro H, Szarmach H, Wroński A, Zajac W.

Przegl Dermatol. 1980 Sep-Oct;67(5):605-8. Polish. No abstract available.

PMID:
6893868

Supplemental Content

Loading ...
Support Center